These findings further reinforce the consistency of the BOT/BAL combination, which has already shown activity and a favorable safety profile across both multiple “warm and cold” tumor types ...

But it wasn’t all sunshine in his first stretch of Major League ball. In June, he suffered a right wrist injury and spent time on Toledo’s 7-day injured list. He returned on July 9 ...

The TP53 gene is a gene that is mutated in many cancers. It is the most common gene mutation found in cancer cells. A tumor-suppressor gene, TP53 codes for a protein that inhibits the development and ...

When a child develops a brain tumor, early diagnosis is essential. Alan Cohen, M.D., director of pediatric neurosurgery at Johns Hopkins Children’s Center, shares the most common signs and symptoms ...

Patients who underwent US therapy and a wrist orthosis not only experienced improvements in their functional status scores compared to those receiving paraffin therapy and a wrist orthosis but ...

Pembrolizumab is under clinical development by Merck and currently in Phase I for Kaposi Sarcoma. According to GlobalData, Phase I drugs for Kaposi Sarcoma have an 84% phase transition success rate ...

The Institutional Review Board of our hospital (Taipei Tzuchi Hospital Institutional Review Board Committee) approved this study, and patients provided informed consent prior to the study.

The American Cancer Society's estimates for soft tissue sarcomas in the United States for 2025 are: About 13,520 new soft tissue sarcomas will be diagnosed (7,600 in males and 5920 in females). About ...